RNS Number : 8836G
Oxford Biomedica PLC
03 October 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDFBVT43

Issuer Name

OXFORD BIOMEDICA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

BlackRock, Inc.

City of registered office (if applicable)

Wilmington

Country of registered office (if applicable)

USA

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

01-Oct-2024

6. Date on which Issuer notified

02-Oct-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.550000

1.680000

5.230000

5529527

Position of previous notification (if applicable)

3.330000

1.680000

5.010000


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BDFBVT43


3743084


3.550000

Sub Total 8.A

3743084

3.550000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Securities Lending



115255

0.100000

Sub Total 8.B1


115255

0.100000%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

CFD



Cash

1671188

1.580000

Sub Total 8.B2


1671188

1.580000%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock, Inc. (Chain 1)

BlackRock Finance, Inc.




BlackRock, Inc. (Chain 1)

BlackRock Holdco 2, Inc.




BlackRock, Inc. (Chain 1)

BlackRock Financial Management, Inc.




BlackRock, Inc. (Chain 1)

BlackRock International Holdings, Inc.




BlackRock, Inc. (Chain 1)

BR Jersey International Holdings L.P.




BlackRock, Inc. (Chain 1)

BlackRock Holdco 3, LLC




BlackRock, Inc. (Chain 1)

BlackRock Cayman 1 LP




BlackRock, Inc. (Chain 1)

BlackRock Cayman West Bay Finco Limited




BlackRock, Inc. (Chain 1)

BlackRock Cayman West Bay IV Limited




BlackRock, Inc. (Chain 1)

BlackRock Group Limited




BlackRock, Inc. (Chain 1)

BlackRock Finance Europe Limited




BlackRock, Inc. (Chain 1)

BlackRock Investment Management (UK) Limited

3.480000

1.690000

5.170000%

BlackRock, Inc. (Chain 2)

BlackRock Finance, Inc.




BlackRock, Inc. (Chain 2)

BlackRock Holdco 2, Inc.




BlackRock, Inc. (Chain 2)

BlackRock Financial Management, Inc.




BlackRock, Inc. (Chain 2)

BlackRock International Holdings, Inc.




BlackRock, Inc. (Chain 2)

BR Jersey International Holdings L.P.




BlackRock, Inc. (Chain 2)

BlackRock Holdco 3, LLC




BlackRock, Inc. (Chain 2)

BlackRock Cayman 1 LP




BlackRock, Inc. (Chain 2)

BlackRock Cayman West Bay Finco Limited




BlackRock, Inc. (Chain 2)

BlackRock Cayman West Bay IV Limited




BlackRock, Inc. (Chain 2)

BlackRock Group Limited




BlackRock, Inc. (Chain 2)

BlackRock Finance Europe Limited




BlackRock, Inc. (Chain 2)

BlackRock Advisors (UK) Limited




10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

BlackRock Regulatory Threshold Reporting Team

Jana Blumenstein

020 7743 3650

12. Date of Completion

02nd October 2024

13. Place Of Completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUORVRSSURRAA
Grafico Azioni Oxford Biomedica (LSE:OXB)
Storico
Da Ott 2024 a Nov 2024 Clicca qui per i Grafici di Oxford Biomedica
Grafico Azioni Oxford Biomedica (LSE:OXB)
Storico
Da Nov 2023 a Nov 2024 Clicca qui per i Grafici di Oxford Biomedica